Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Current Issues in Pharmacy and Medical Sciences
Volume 31 (2018): Issue 1 (March 2018)
Open Access
Evaluation of the impact of the proteasome inhibitor on calcium channel expression in cardiomyocytes treated with doxorubicin
Agnieszka Korga
Agnieszka Korga
,
Milena Soroka
Milena Soroka
,
Karolina Wicha
Karolina Wicha
,
Ewelina Humeniuk
Ewelina Humeniuk
,
Grzegorz Adamczuk
Grzegorz Adamczuk
,
Magdalena Iwan
Magdalena Iwan
,
Marcin Sysa
Marcin Sysa
and
Jaroslaw Dudka
Jaroslaw Dudka
| Apr 11, 2018
Current Issues in Pharmacy and Medical Sciences
Volume 31 (2018): Issue 1 (March 2018)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Apr 11, 2018
Page range:
18 - 21
Received:
Sep 25, 2017
Accepted:
Nov 13, 2017
DOI:
https://doi.org/10.1515/cipms-2018-0004
Keywords
doxorubicin
,
bortezomib
,
proteasome
,
cardiotoxicity
,
calcium channels
© 2018 Agnieszka Korga et al., published by De Gruyter Open
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.